Heartbeam Inc. Warrant (BEATW) offers a unique investment prospect linked to Heartbeam Inc., a pioneering healthcare technology firm dedicated to revolutionizing cardiac diagnostics via advanced artificial intelligence and digital health solutions. The company's innovative platform aims to increase the accuracy of myocardial infarction diagnoses, enabling timely and effective interventions that enhance patient care. As the demand for remote monitoring and telehealth services in cardiovascular health continues to rise, Heartbeam Inc. is strategically positioned to leverage this growth, making BEATW an appealing option for institutional investors interested in impactful and forward-thinking medical technologies.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | -164.20% |
| Return on Assets | -90.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.30 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $5.19M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |